Pharmaceutical and Cosmetic Use of Lipids
Industrial and Nonedible Products from Oils and Fats
Ernesto M. Hernandez,
Ernesto M. Hernandez
Advanced Lipid Technologies, Tomball, TX, USA
Search for more papers by this authorErnesto M. Hernandez,
Ernesto M. Hernandez
Advanced Lipid Technologies, Tomball, TX, USA
Search for more papers by this authorAbstract
Fats and oils in general are considered reliable ingredients, excipients or carriers in many pharmaceutical and cosmetic formulations. More recently, biological and functional properties as well as health benefits of many fatty acids and lipid phytochemicals have been studied for their potential applications in health products and disease prevention. This has resulted in the development of new products and applications of these bioactives into more specialized pharmaceutical and cosmetic products such as coadjuvants, skin emolliency agents, and transdermal carriers. New, more specifically targeted applications of lipids in pharma and cosmeceutical fields also include the manufacture of lipid vesicles with entrapped bioactive elements able to partition into the skin layers and deliver drugs and bioactive cosmetics transdermally. Lipids used in pharmaceutical and cosmetics require higher standards of purity and have to fulfill more stringent regulatory specifications. Therefore it is necessary to conduct additional processing steps to remove contaminants and other impurities to trace or non-detectable levels. In order to make lipids more functional and recover lipid biological actives new processing techniques have to be applied such as molecular distillation, supercritical extraction, and fractionation techniques.
References
- 1 P.J. Quinnand and X. Wang (ed.) (2008). Lipids in Health and Disease. New York, NY: Springer.
- 2 FAO (2010). Fats and fatty acids in human nutrition. Report of an expert consultation, Rome, Italy.
- 3Mead, J.F. (1986). Lipids: Chemistry, Biochemistry, and Nutrition. New York: Plenum Press.
10.1007/978-1-4613-2107-1 Google Scholar
- 4Kris-Etherton, P.M., Harris, W.S., and Appel, L.J. (2002). Circulation 106 (21): 2747–2757.
- 5Shahidi, F. (2011). In: Omega 3 Oils: Applications in Functional Foods (ed. E. Hernandez and H. Hosokowa), 2011. Urbana, IL: AOCS Press.
- 6Drover, J., Hoffman, D.R., Castaneda, Y.S. et al. (2009). Child Dev. 80: 1376–1384.
- 7Volker, D. and Garg, M. (1996). J. Clin. Biochem. Nutr. 20: 83–97.
- 8Clissold, D. (1999). In: Lipids in Health and Nutrition (ed. J.H.P. Tyman). Cambridge, UK: Royal Society of Chemistry.
10.1533/9781845698386.115 Google Scholar
- 9Choo, W., Birch, J., and Dufour, J.P. (2007). J. Food Compos. Anal. 20: 202–211.
- 10Oomah, B.D., Busson, M., Godfrey, D.V., and Drover, J.C.G. (2002). Food Chem. 76: 33–43.
- 11Nichols, P.D. (2007). In: Long-Chain Omega-3 Specialty Oils (ed. H. Breivik). Bridgwater, England: The Oily Press.
- 12Kris-Etherton, P.M., Harris, W.S., and Appel, L.J. (2003). Arterioscler. Thromb. Vasc. Biol. 23 (2): 151–152.
- 13Jensen, C.L., Maude, M., Anderson, R.E., and Heird, W.C. (2000). Am. J. Clin. Nutr. 71: 292S–299S.
- 14White, P.J., St-Pierre, P., Charbonneau, A. et al. (2014). Nat. Med. 6: 664–669.
- 15Pottala, J.V., Yaffe, K., Robinson, J.G. et al. Neurology 82 (5): 435–442.
- 16Chung, M.K. (2008). Curr. Treat Options Cardiovasc. Med. 10: 398–407.
- 17Wang, C., Harris, W.S., Chung, M. et al. (2006). Am. J. Clin. Nutr. 84: 5–17.
- 18Burdge, G.C. and Calder, P.C. (2005). Reprod. Nutr. Dev. 45 (5): 581–597.
- 19Hoy, S.M. and Keating, G.M. (2009). Drugs 69 (8): 1077–1105.
- 20Rupp, H. (2009). Adv. Ther. 26 (7): 675–690.
- 21Hernandez, E. and de Jong, L. (2011). In: Omega 3 Oils: Applications in Functional Foods (ed. E.M. Hernandez and M. Hosokawa). Champaign, IL: AOCS Press.
- 22Fan, Y.Y. and Chapkin, R.S. (1998). J. Nutr. 128 (9): 1411–1414.
- 23Pham, H., Vang, K., and Ziboh, V.A. (2006). Prostaglandins Leukot. Essent. Fat. Acids 74: 271–282.
- 24Hadley, K.B., Ryan, A.S., Forsyth, S. et al. (2016). Nutrients 8: 216.
- 25Wu, D., Meydani, M., Leka, L.S. et al. (1999). Am. J. Clin. Nutr. 70: 536–543.
- 26Schirmer, M.A. and Phinney, S.D. (2007). J. Nutr. 137: 1430–1435.
- 27Simon, D. (2014). Adv. Ther. 31: 180–188.
- 28Lampi, A.M. and Kamal-Eldin, A. (1998). J. Am. Oil Chem. Soc. 75: 1699–1703.
- 29Kris-Etherton, P.M. (1999). Circulation 100: 1253–1258.
- 30Vessbyl, B., Uusitupa, M., Hermansen, K. et al. (2001). Diabetologia 44: 312–319.
- 31Puertollano, M.A., Puertollano, E., Alvarez de Cienfuegos, G., and Pablo, M.A. (2007). Br. J. Nutr. Suppl 1: S54–S58.
- 32Kelly, G.S. (2001). Altern. Med. Rev. 6: 367–382.
- 33Whigham, L.D., Watras, A.C., and Schoeller, D.A. (2007). Am. J. Clin. Nutr. 85: 1203–1211.
- 34Kennedy, A., Martinez, K., Schmidt, S. et al. (2010). J. Nutr. Biochem. 21: 171–179.
- 35Lee, K.W., Lee, H.J., Cho, H.Y., and Kim, W.J. (2005). Crit. Rev. Food Sci. Nutr. 45 (2): 135–144.
- 36Ochoa, J.J., Farquharson, A.J., Grant, I. et al. (2004). Carcinogenesis 25: 1185–1191.
- 37Yang, B. and Kallio, H.P. (2001). J. Agric. Food Chem. 49: 1939–1947.
- 38Ozogul, Y., Ozogu, F., Cicek, E. et al. (2008). Int. J. Food Sci. Nutr. 29: 1–12.
- 39Garg, M.L., Blake, R.J., and Wills, R.B. (2003). J. Nutr. 133: 1060–1063.
- 40Zadernowski, R., Nowak-Polakowska, H., Lossow, B., and Nesterowicz, J. (1997). J. Food Lipids 4 (1997): 165–172.
- 41Mozaffarian, D., de Oliveira Otto, M.C., Lemaitre, R.N. et al. (2013). Am. J. Clin. Nutr. 97: 854–861.
- 42Morgan, N.G. and Dhayal, S. (2010). Prostaglandins Leukot. Essent. Fat. Acids 82: 231–236.
- 43Hernandez, E., Rusli, M. and Griffin, M. (12 Sep 2017). U.S. Patent 9,758,536 (to Omega Protein Corp.)
- 44Yang, Z.H., Miyahara, H., and Hatanaka, A. (2011). Lipids Health Dis. 10: 120.
- 45Mozaffarian, D., Cao, H., King, I.B. et al. (2010). Ann. Intern. Med. 153: 790–799.
- 46 G. Cevc and F. Paltauf (ed.) (2003). Phospholipids: Characterization, Metabolism, and Novel Biological Applications. Champaign, IL: AOCS Press.
- 47Crook, T.H., Tinklenberg, J., Yesavage, J. et al. (1991). Neurology 41 (5): 644–649.
- 48Hossen, M. and Hernandez, E. (2005). Lipids 39 (8): 777–782.
- 49Hossen, M. and Hernandez, E. (2005). Eur. J. Lipid Sci. Technol. 107: 730–736.
- 50Fitch-Haumann, B. (1997). Inform 8 (10): 1004–1011.
- 51Willis, W.M., Lencki, R.W., and Marangoni, A.G. (1998). Crit. Rev. Food Sci. Nutr. 38 (8): 639–674.
- 52Yamamoto, K., Asakawa, H., Tokunaga, K. et al. (2001). J. Nutr. 131: 3204–3207.
- 53McNeill, G.P., Rawlings, C., and Peilow, A.C. (1999). J. Am. Oil Chem. Soc. 76: 443–450.
- 54Garcia, H.S., Arcos, J.A., Ward, D.J., and Hill, C.G. (2000). Biotechnol. Bioeng. 70: 587–591.
- 55Rocha, A. and Hernandez, E. (2004). J. Am. Soc. Oil Chem. 81: 685–689.
- 56Goni, F.M. and Alonso, A. (2006). Biochim. Biophys. Acta 1758: 1902–1921.
- 57Gangoiti, P., Camacho, L., Arana, L. et al. (2010). Prog. Lipid Res. 49: 316–334.
- 58Coderch, L., López, O., de la Maza, A., and Parra, J.L. (2003). Am. J. Clin. Dermatol. 4 (2): 107–129.
- 59Farrell, P.M. (1988). In: Modern Nutrition in Health and Disease (ed. V. Young and M. Shils). Philadelphia, PA: Lea and Fabiger Press.
- 60Ju, J., Picinich, S.C., Yang, Z. et al. (2010). Carcinogenesis 31: 533–542.
- 61Yoshida, Y., Saito, Y., Jones, L.S., and Shigeri, Y. (2007). J. Biosci. Bioeng. 104 (6): 439–445.
- 62 R. Blomhoff (ed.) (1994). Vitamin A in Health and Disease. New York, NY: Marcel Dekker.
10.1201/9781482277562 Google Scholar
- 63Conly, J.M. and Stein, K. (1992). Prog. Food Nutr. Sci. 16 (4): 307–343.
- 64Pelletier, X., Belbraouet, S., Mirabel, D. et al. (1995). Ann. Nutr. Metab. 39: 291–295.
- 65Gabay, O., Sanchez, C., Salvat, C. et al. (2010). Osteoarthr. Cartil. 18 (1): 106–116.
- 66Awad, A.B. and Fink, C.S. (2000). J. Nutr. 130: 2127–2130.
- 67Bradford, P.G. and Awad, A.B. (2007). Mol. Nutr. Food Res. 51: 161–170.
- 68Woyengo, T.A., Ramprasath, V.R., and Jones, P.J. (2009). Eur. J. Clin. Nutr. 63: 813–820.
- 69Ariza Ortega, J.A., Martínez Zavala, A., Cano Hernández, M., and Díaz Reyes, J. (2012). Cent. Eur. J. Chem. 10 (6): 1773–1778.
- 70Kelly, G.S. (1999). Altern. Med. Rev. 4: 29–36.
- 71Reddy, L.H. and Couvreur, P. (2009, 2009). Adv. Drug Deliv. Rev. 61: 1412–1426.
- 72Fox, C.B. (2009). Molecules 14 (9): 3286–3312.
- 73Warleta, F., Campos, M., Allouche, Y. et al. (2010). Food Chem. Toxicol. 48: 1092–1100.
- 74Hernandez, E. (2015). In: Functional Dietary Lipids: Food Formulation, Consumer Issues and Innovation for Health (ed. T.M. Sanders). London, UK: Elsevier-Woodhead Publishing.
- 75Bolling, B.W., Chen, C.Y., and McKay, D. (2011). Nutr. Res. Rev. 24: 244–275.
- 76 F. Shahidi and M. Naczk (ed.) (2004). Phenolics in Food and Nutraceuticals. Boca Raton, FL: CRC Press, Taylor & Francis Group.
- 77 US Department of Agriculture. Database for the flavonoid content of selected foods, release 2.1. http://www.ars.usda.gov/nutrientdata (accessed September 2017).
- 78Gu, L., Kelm, M.A., Hammerstone, J.F. et al. (2004). J. Nutr. 134: 613–617.
- 79Thompson, L.U., Boucher, B.A., Liu, Z. et al. (2006). Nutr. Cancer 54: 184–201.
- 80Schäfer-Korting, M., Mehnert, W., and Korting, H.C. (2007). Adv. Drug Deliv. Rev. 59: 427–443.
- 81Charman, W.N. (2000). J. Pharm. Sci. 89 (8): 967–978.
- 82Bolzinger, M.A., Briançon, S., Pelletier, J., and Chevalier, Y. (2012). Curr. Opin. Colloid Interface Sci. 17: 156–165.
- 83Bouwstraa, J.A., Honeywell-Nguyena, P.L., Goorisa, G.S., and Ponec, M. (2003). Prog. Lipid Res. 42: 1–36.
- 84Lampe, M.A., Burlingame, A.L., Whitney, J. et al. (1883). J. Lipid Res. 24: 120–130.
- 85Wertz, P.W. (2000). Acta Derm. Venereol. Suppl. (Stockh) 208: 7–11.
- 86Tsai, J.C., Guy, R.H., Thornfeldt, C.R. et al. (1996). J. Pharm. Sci. 85 (6): 643–648.
- 87Pappas, A. (2009). Dermato-Endocrinology 1 (2): 72–76.
- 88Jain, S., Patel, N., Shah, M.K. et al. (2017). J. Pharm. Sci. 106 (2): 423–445.
- 89Kendall, A.C., Kiezel-Tsugunova, M., Brownbridge, L.C. et al. (2017). Biochim. Biophys. Acta 1859: 1679–1689.
- 90Kim, Y.C., Lee, S.H., Choi, W.H. et al. (2016). J. Drug Target. 24 (10): 943–951.
- 91Javadzadeh, Y. and Azharshekoufeh Bahari, L. (2017). In: Nano- and Microscale Drug Delivery Systems (ed. A. Grumezescu). New York: Elsevier.
10.1016/B978-0-323-52727-9.00008-X Google Scholar
- 92Egbaria, K. and Weiner, N. (1990). Adv. Drug Deliv. Rev. 5: 287–300.
- 93Ogiso, T., Niinaka, N., and Iwaki, M. (1996). J. Pharm. Sci. 85 (1): 57–64.
- 94Basnet, P., Hussain, H., Tho, I., and Skalko-Basnet, N. (2012). J. Pharm. Sci. 101 (2): 598–609.
- 95Hughes, J., Yadava, P., and Mesaros, R. (2010). Methods Mol. Biol. 605: 445–459.
- 96Dorrani, M., Garbuzenko, O.B., Minko, T., and Michniak-Kohn, B. (2016). J. Control. Release 228: 150–158.
- 97Iwaszkiewicz, K.S. and Hua, S. (2014). Pain Physician 17 (6): E719–E735.
- 98Ning, M., Guo, Y., Pan, H. et al. (2005). Drug Dev. Ind. Pharm. 31 (4-5): 375–383.
- 99Isailovi, B.D., Kosti, I.T., Zvonar, A. et al. (2013). Innov. Food Sci. Emerg. Technol. 19: 81–189.
- 100Bucalo, B.D., Mirikitani, E.J., and Moy, R.L. (1998). Dermatol. Surg. 24 (5): 537–541.
- 101Mishra, D., Mishra, P.K., Dubey, V. et al. (2008). Eur. J. Pharm. Sci. 33 (4-5): 424–433.
- 102Tyagi, R.K., Garg, N.K., Jadon, R. et al. (2015). Vaccine 33 (36): 4630–4638.
- 103Godin, B. and Touitou, E. (2003). Crit. Rev. Ther. Drug Carrier Syst. 20 (1): 63–102.
- 104Touitou, E., Godin, B., and Wiess, C. (2000). Drug Dev. Res. 50: 406–415.
- 105Maheshwari, R.G., Tekade, R.K., Sharma, P.A. et al. (2012). Saudi Pharm. J. 20 (2): 161–170.
- 106Dubey, V., Mishra, D., Nahar, M. et al. (2010). Nanomedicine 6 (4): 590–596.
- 107Verma, P. and Pathak, K. (2012). Nanomedicine 8 (4): 489–496.
- 108Zhang, Y.T., Shen, L.N., Wu, Z.H. et al. (2014). Int. J. Pharm. 471 (1-2): 449–452.
- 109Swain, S., Beg, S., and Babu, S.M. (2016). Recent Pat. Drug Deliv. Formul. 10 (1): 59–71.
- 110Wattamwar, M.M., Ratnaparkhi Mukesh, P., and Chaudhari Shilpa, P. (2014). Asian J. Pharm. Technol. Innov. 02 (06).
- 111Dudala, T.B., Yalavarthi, P.R., Vadlamudi, H.C. et al. (2014). Int. J. Pharm. Invest. 4 (4): 149–155.
- 112Tursilli, R., Casolari, A., Iannuccelli, V., and Scalia, S. (2006). J. Pharm. Biomed. Anal. 4: 910–914.
- 113Muller, R.H., Mader, K., and Gohla, S. (2000). Eur. J. Pharm. Biopharm. 50 (1): 161–177.
- 114Shah, M.K., Madan, P., and Lin, S. (2014). Pharm. Dev. Technol. 19 (4): 475–485.
- 115Shah, M.K., Madan, P., and Lin, S. (2014). Pharm. Dev. Technol. 29: 1–9.
- 116Trombino, S., Cassano, R., Muzzalupo, R. et al. (2009). Colloids Surf. B: Biointerfaces 72 (2): 181–187.
- 117Obeidat, W.M., Schwabe, K., Muller, R.H., and Keck, C.M. (2010). Eur. J. Pharm. Biopharm. 76 (1): 56–67.
- 118Pardeike, J., Hommoss, A., and Muller, R.H. (2009). Int. J. Pharm. 366 (1-2): 170–184.
- 119Fan, H., Liu, G., Huang, Y. et al. (2014). Appl. Surf. Sci. 288: 93–200.
- 120Wang, J., Wang, H., Zhou, X. et al. (2012). J. Nanosci. Nanotechnol. 12 (3): 2136–2148.
- 121Ravani, L., Esposito, E., Bories, C. et al. (2013). Int. J. Pharm. 454 (2): 695–702.
- 122Donatella, P., Annalisa, H.S.S., Felisa, C. et al. (2011). Drug Deliv. Lett. 1 (1): 32–39.
- 123Bruge, F., Damiani, E., Puglia, C. et al. (2013). Int. J. Pharm. 455 (1-2): 348–356.
- 124Hauss, D.J., Fogal, S.E., Ficorilli, J.V. et al. (1998). J. Pharm. Sci. 87 (2): 164–169.
- 125Pouton, C.W. (2000). Eur. J. Pharm. Sci. 11 (Suppl. 2): S93–S98.
- 126O'Driscoll, C.M. (2002). Eur. J. Pharm. Sci. 15: 405–415.
- 127Porter, C.J., Trevaskis, N.L., and Charman, W.N. (2007). Nat. Rev. Drug Discov. 6: 231–248.
- 128Pouton, C.W. and Porter, C.J. (2008). Adv. Drug Deliv. Rev. 60: 625–637.
- 129Charman, W.N., Porter, C.J.H., Mithani, S., and Dressman, J.B. (1997). J. Pharm. Sci. 86 (3): 269–282.
- 130Garzon-Arburbeh, A., Poupaert, J.H., Claesen, M., and Dumont, P. (1986). J. Med. Chem. 29: 687–691.
- 131Porter, C.J. (1997). Crit. Rev. Ther. Drug Carrier Syst. 14: 333–393.
- 132Hashizume, M., Douen, T., Murakami, M. et al. (1992). J. Pharm. Pharmacol. 44: 555–559.
- 133Verhoef, J.C., Bodde, H.E., de Boer, A.G. et al. (1990). Eur. J. Drug Metab. Pharmacokinet. 15: 83–93.
- 134Patel, D., McKinely, B.D., Davis, T.P. et al. (1997). Bioconjug. Chem. 8: 434–441.
- 135Hunt, J.N. and Knox, M.T. (1968). J. Physiol. 194: 327–336.
- 136Wagnera, D., Langguth, H.S., Hanafy, A. et al. (2001). Adv. Drug Deliv. Rev. 50 (Suppl. 1): S13–S31.
- 137Gershkovich, P. and Hoffman, A. (2007). Eur. J. Pharm. Sci. 32: 24–32.
- 138Strickley, R.G. (2004). Pharm. Res. 21: 201–230.
- 139Arbit, E., Goldberg, M., Gomez-Orellana, I., and Majuru, S. (2006). Thromb. J. 4: 6.
- 140Holm, R., Porter, C.J., Edwards, G.A. et al. (2003). Eur. J. Pharm. Sci. 20 (1): 91–97.
- 141Porter, C.J.H. and Charman, W.N. (1996). In: Models for Assessing Drug Absorption and Metabolism (ed. R.T. Borchardt, P.L. Smith and G. Wilson), 85–102. New York, NY: Plenum Press.
10.1007/978-1-4899-1863-5_6 Google Scholar
- 142Müller, R.H., Freitas, C., zur Mühlen, A., and Mehnert, W. (1996). Eur. J. Pharm. Sci. 4 (1): S75.
10.1016/S0928-0987(97)86243-4 Google Scholar
- 143Benita, S. and Levy, M.Y. (1993). J. Pharm. Sci. 82 (11): 1069–1079.
- 144Yang, S.C. and Benita, S. (2000). Drug Dev. Res. 50 (3-4): 476–486.
- 145von Corswant, C., Thorén, P., and Engström, S. (1998). J. Pharm. Sci. 87 (2): 200–208.
- 146 G. Baki and S.A. Kenneth (ed.) (2015). Introduction to Cosmetic Formulation and Technology. New York, NY: Wiley.
- 147Norlén, L. (2003). Int. J. Cosmet. Sci. 25 (5): 209–226.
- 148Feingold, K.R. and Elias, P.M. (2014). Biochim. Biophys. Acta 1841: 280–294.
- 149Harding, C.R., Watkinson, A., and Rawling, A.V. (2000). Int. J. Cosmet. Sci. 22: 21–52.
- 150Sachs, D.L., Rittié, L., Chubb, H.A. et al. (2013). J. Cosmet. Dermatol. 12 (2): 108–115.
- 151Ganceviciene, R., Liakou, A.I., Theodoridis, A. et al. (2012). Dermatoendocrinology 4 (3): 308–319.
- 152Ahmad, I., Akhter, S., Ahmad, M.Z. et al. (2014). Pharm. Dev. Technol. 19 (4): 460–467.
- 153Lin, F.H., Lin, J.Y., Gupta, R.D. et al. (2005). J. Invest. Dermatol. 125 (4): 826–832.
- 154Elias, P.M. and Ghadially, R. (2002). Ger. Dermatol. 18: 103–120.
- 155Rawlings, A.V., Davies, A., Carlomusto, M. et al. (1996). Arch. Dermatol. Res. 288: 383–390.
- 156Froebe, C.L., Simion, F.A., Ohlmeyer, H. et al. (1990). J. Soc. Cosmet. Chem. 41 (1): 51–65.
- 157Johnson, A.W. (2002). In: Skin Moisturization (ed. J.J. Leyden and A.V. Rawlings), 323. New York: Marcel Dekker.
- 158Leveque, J.L. and Saint-Leger, D. (2002). In: Skin Moisturization (ed. J.J. Leyden and A.V. Rawlings), 353. New York: Marcel Dekker.
- 159Ramíreza, R., Garay, I., Álvarez, J. et al. (2008). Sep. Purif. Technol. 63: 552–557.
- 160Zemstov, A., Gaddis, M., and Montalvo-Lugo, V.M. (1996). Aust. J. Dermatol. 37: 159–162.
- 161Yoganathan, S., Nicolosi, R., Wilson, T. et al. (2003). Lipids 38: 603–607.
- 162Unnithana, A.R., Tirupathi Pichiahb, P.B., Gnanasekaranc, G. et al. (2012). Colloids Surf. A Physicochem. Eng. Asp. 415: 454–460.
- 163Lohani, A., Verma, A., Joshi, H. et al. (2014). ISRN Dermatol. 22: 843687.
- 164Nemitz, M.C., Moraes, R.C., Koester, L.S. et al. (2015). Phytochem. Rev. 14 (5): 849–869.
- 165Schwarz, J.C., Baisaeng, N., Hoppel, M. et al. (2013). Int. J. Pharm. 447 (1–2): 213–217.
- 166Khameneh, B., Halimi, V., Jaafari, M.R., and Golmohammadzadeh, S. (2015). Iran J. Basic Med. Sci. 18 (1): 58–63.
- 167Teskac, K. and Kristl, J. (2010). Int. J. Pharm. 390 (1): 61–69.
- 168Takahashi, M., Kitamoto, D., Asikin, Y. et al. (2009). J. Oleo Sci. 58 (12): 643–650.
- 169Pando, D., Matos, M., Gutiérrez, G., and Pazos, C. (2015). Colloids Surf. B: Biointerfaces 128: 398–404.
- 170Verma, P. and Pathak, K. (2010). J. Adv. Pharm. Technol. Res. 1 (3): 274–282.
- 171Teeranachaideekul, V., Müller, R.H., and Junyaprasert, V.B. (2007). Int. J. Pharm. 340: 198–206.
- 172Vinardell, M.P. and Mitjans, M. (2015). Cosmetics 2: 342–354.
- 173Jee, J.P., Lim, S.J., Park, J.S., and Kim, C.K. (2006). Eur. J. Pharm. Biopharm. 63: 134–139.
- 174Ro, J., Kim, Y., Kim, H. et al. (2015). Korean J. Physiol Pharmacol. 19 (1): 59–64.
- 175 R.D. O'Brien, W.E. Farr, and P.J. Wan (ed.) (2000). Introduction to Fats and Oils Technology, 2e. Champaign, IL: AOCS Press.
- 176 E. Hernandez and A. Kamal-Eldin (ed.) (2013). Processing and Nutrition of Fats and Oils, vol. 2013. Wiley-Blackwell Publishing.
10.1002/9781118528761 Google Scholar
- 177Hernandez, E. and Rathbone, S. (10 Sep 2002). U.S. Patent. 6,448,423 (to the Texas A&M University System).
- 178O'Brien, R. (1998). Fats and Oils. Formulating and Processing Applications. Lancaster, PA: Technomic Publishing.
- 179 E. Hernandez and A. Kamal-Eldin (ed.) (2013). In: Wiley-Blackwell Publishing.
- 180Skaliotis, L. (2011). Lipid Technol. 23: 204–206.
- 181Breivik, H. and Thorstad, O. (2005). Lipid Technol. 17: 55–58.
- 182Solaesa, A.G., Sanz, M.T., Falkeborg, M. et al. (2016). Food Chem. 190: 960–967.
- 183Batistella, C.B. and Wolf-Maciel, M.R. (1998, 1998). Comput. Chem. Eng. 22: S53–S60.
- 184Watanabe, Y., Nagao, T., Hirota, Y. et al. (2004). J. Am. Oil Chem. Soc. 81 (4): 339–345.
- 185Pietsch, A. and Jaeger, P. (2007). Eur. J. Lipid Sci. Technol. 109: 1077–1082.
- 186Breivik, H., Haraldsson, G.G., and Kristinsson, B. (1997). J. Am. Oil Chem. Soc. 11: 1425–1429.
- 187Breivik, H., Boslashed, B., Dahl, K.H. et al. (16 Dec 1997). US Patent 5,698,594 (to Norsk Hydro A.S).
- 188Brinton, E.A. and Preston, M. (2017). Lipids Health Dis. 16: 23.
- 189Khaw, K.Y., Parat, M.O., Shaw, P.N., and Falconer, J.R. (2017). Molecules 22: 1186.
- 190Pettinello, G., Bertucco, A., Pallado, P., and Stassi, A. (2000). J. Supercrit. Fluids 19: 51–60.
- 191Salminen, W.F. Jr. (2002). Int. J. Cosmet. Sci. 24 (4): 217–224.
- 192Schliemann-Willers, S., Wigger-Alberti, W., Kleesz, P. et al. (2002). Contact Dermatitis 46 (1): 6–12.
